Can MRI scans help predict chemo-radiation success in cervical cancer?
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial uses MRI scans taken before treatment to see if they can predict how well chemo-radiation will work for locally advanced cervical cancer. It aims to help doctors know which patients might benefit most from this therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with locally advanced cervical cancer (stage 1B to 4B).
- You received radiation and chemotherapy (without surgery) as your main treatment.
- Your treatment ended at least 2 years ago.
- A sample of your cancer taken before treatment (a biopsy) is available for review.
- You are willing to let researchers use your medical data and do not object to the study.
- You have health insurance or are covered by a national health plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a more precise way to deliver radiation for locally advanced cervical cancer using MRI guidance during treatment, along with chemotherapy. It may help shrink tumors more effectively while aiming to reduce side effects by targeting the right areas.
This feasibility study tests whether an MRI-guided radiation approach can be used safely and practically for people with certain stages of cervical cancer. It’s meant to help doctors plan radiation more accurately, while checking whether the treatment process works well.
This study uses MRI scans to try to predict whether your rectal cancer completely disappears after pre-surgery chemoradiotherapy. The goal is to better personalize treatment decisions, possibly helping some patients avoid surgery.
This study looks at MRI scans from people with cervical cancer to predict how well they might do with radiotherapy. It aims to help doctors better tailor treatments and improve survival.
This trial uses MRI scans during chemoradiation to improve treatment accuracy for cervical cancer. It may help patients who need standard chemoradiation plus brachytherapy.
This trial studies whether a special MRI scan can better predict whether early cervical cancer has spread into tiny lymph and blood vessels (lymphovascular space invasion) before surgery. If it works, it may help doctors plan the best treatment after surgery.
Hear when a new Uterine Cervical Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.